Table 1 Clinical characteristics in patients with and without concomitant T2DM

Age (years)

70 ± 9

70 ± 11

n.s.

Men/Women, n (%)

23/27 (46/54%)

44/36 (55/45%)

n.s.

Symptoms, n (%)^a

31 (62%)

41 (51%)

n.s.

Hypertension, n (%)

45 (90%)

62 (78%)

n.s.

Chronic kidney disease, n (%)

16 (32%)

17 (21%)

n.s.

Body-mass index (kg/m²)

31 ± 5

28 ± 4

0.003

Mean blood pressure (mm Hg)

90 ± 10

89 ± 10

n.s.

Systolic blood pressure (mm Hg)

131 ± 16

130 ± 18

n.s.

Glycated hemoglobin (%)

7.1 ± 0.8

–

–

Medications, n (%)

 ACEI or ARB

30 (60%)

43 (54%)

n.s.

 Beta-blocker

25 (50%)

34 (43%)

n.s.

 Diuretic

20 (40%)

27 (34%)

n.s.

 Calcium channel blockers

17 (34%)

24 (30%)

n.s.

 Statin

38 (76%)

50 (62%)

n.s.

 Metformin

47 (94%)

–

–

 Insulin

16 (32%)

–

–